PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
14-Mar-2025 Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA Dermapharm Holding SE
14-Mar-2025 BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS BioVersys AG
13-Mar-2025 AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update AC Immune
13-Mar-2025 SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease SpliceBio
13-Mar-2025 ProQR Announces Year End 2024 Operating and Financial Results ProQR Therapeutics
13-Mar-2025 Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer Mainz BioMed N.V.
13-Mar-2025 Bayer and Hurdle Announce Breakthrough in Aging Research Bayer
13-Mar-2025 Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity Roche
13-Mar-2025 Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option Gilead
13-Mar-2025 Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin SYNBIOTIC SE
13-Mar-2025 Bupa UK insurance to cover Oxford BioDynamics’ EpiSwitch® PSE prostate cancer test Oxford BioDynamics Plc
13-Mar-2025 Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty Heidelberg Pharma
13-Mar-2025 Heat-sealed: Henkel develops fully recyclable coating for primary and secondary packaging Henkel
13-Mar-2025 Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older Otsuka Pharmaceutical Europe Ltd
13-Mar-2025 Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty Heidelberg Pharma AG
13-Mar-2025 Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results Nyxoah SA.
13-Mar-2025 DocMorris achieves 2024 targets, expects Rx growth of around 50 per cent in the first quarter of 2025 and plans capital increase DocMorris AG
12-Mar-2025 Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty Heidelberg Pharma AG
12-Mar-2025 ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV ViiV Healthcare
12-Mar-2025 ReiThera to Unveil ReiCell-AAV Platform for High-Efficiency Gene Therapy AAV Production, Adding to MVA and GRAd Vector Capabilities ReiThera